Titan Pharmaceuticals's total assets for Q were $6.65M, a decrease of -33.53% from the previous quarter. TTNP total liabilities were $559.00K for the fiscal quarter, a -70.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.